Provided by Tiger Trade Technology Pte. Ltd.

Evaxion Biotech A/S

3.22
-0.0050-0.16%
Volume:16.86K
Turnover:54.02K
Market Cap:26.81M
PE:-2.95
High:3.24
Open:3.22
Low:3.17
Close:3.22
52wk High:12.15
52wk Low:2.77
Shares:8.34M
Float Shares:5.53M
Volume Ratio:0.83
T/O Rate:0.30%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0886
EPS(LYR):-1.2027
ROE:-109.86%
ROA:-25.97%
PB:2.81
PE(LYR):-2.67

Loading ...

Evaxion A/S reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 07

Denmark's Evaxion Q1 net loss widens

Reuters
·
May 07

BRIEF-Evaxion Q1 Basic EPS USD -0.01

Reuters
·
May 07

Evaxion Q1 Pretax Profit USD -3.845 Million

THOMSON REUTERS
·
May 07

Evaxion Q1 Net Income USD -3.629 Million

THOMSON REUTERS
·
May 07

Evaxion Announces Business Update and First Quarter 2026 Financial Results

THOMSON REUTERS
·
May 07

Press Release: Evaxion announces business update and first quarter 2026 financial results

Dow Jones
·
May 07

Evaxion A/S expected to post a loss of 30 cents a share - Earnings Preview

Reuters
·
May 05

Evaxion to report Q1 results, host business update call

Reuters
·
May 04

Press Release: Evaxion to announce business update and first quarter 2026 financial results on May 7, 2026

Dow Jones
·
May 04

BRIEF-Evaxion Promotes Birgitte Rønø To Joint Role Of Chief Scientific And Chief Operating Officer

Reuters
·
Apr 27

Evaxion Promotes Birgitte RØNØ to Joint Role of Chief Scientific and Chief Operating Officer

THOMSON REUTERS
·
Apr 27

Evaxion promotes Birgitte Rønø to joint role of Chief Scientific and Chief Operating Officer

GlobeNewswire
·
Apr 27

Evaxion files Form 3 for director Jens Bitsch-Norhave###

Reuters
·
Apr 25

European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading

MT Newswires Live
·
Apr 24

Evaxion Price Target Maintained With a $16.00/Share by HC Wainwright & Co.

Dow Jones
·
Apr 24

Evaxion shareholders adopted 2025 annual report at annual general meeting

Reuters
·
Apr 22

European Equities Traded in the US as American Depositary Receipts Sharply Lower in Tuesday Trading

MT Newswires Live
·
Apr 21

Evaxion says EVX-01 demonstrates 86% vaccine target precision in trial

TIPRANKS
·
Apr 18

Evaxion’s AI-Immunology™ Platform Demonstrates 86% Vaccine Target Precision in Phase 2 Personalized Cancer Vaccine Trial

THOMSON REUTERS
·
Apr 18